Mehmet Ali Felekoğlu

Mehmet Ali Felekoğlu

Auto-generated profile, based on publicly available information

Mehmet Ali Felekoğlu

Department of Cardiology, Yunus Emre State Hospital, Eskişehir, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
EAEngin Algül
Engin Algül
HSHamza Sunman
Hamza Sunman
MDMuhammet Dural
Muhammet Dural
IGİlKin Guli̇yEv
İlKin Guli̇yEv
MAMert Aker
Mert Aker
TCTolga Cimen
Tolga Cimen
Background/aim: Ticagrelor is a drug widely used in patients with acute coronary syndromes (ACS) that specifically increases the plasma level of adenosine, which is likely to cause atrial fibrillation (AF). Therefore, in this study we aimed to investigate the electrocardiographic and echocardiographic predictors of AF development after P2Y12 receptor antagonists in ACS patients. Materials and methods: This cross-sectional study included 831 patients with ACS (486 [58.5%] with ST elevated myocardial infarction [STEMI] and 345 [41.5%] with non-ST elevated myocardial infarction [NSTEMI]). Patients were divided into ticagrelor (n = 410) and clopidogrel (n 421) groups. P wave properties including P wave dispersion and atrial electromechanical conduction properties were measured as AF predictors with surface ECG and tissue Doppler imaging. Results: Baseline characteristics such as age, sex, heart rate, blood pressure, and laboratory parameters were almost the same in the ticagrelor and clopidogrel groups. The statistical analysis showed no significant difference in P wave dispersion (PWD) between ticagrelor and clopidogrel groups (40.98 +/- 12 ms versus 40.06 +/- 12 ms, P = 0.304). Subgroups analysis according to ACS types also showed no significant difference in PWD (NSTEMI: 41.16 +/- 13.8 ins versus 40.76 +/- 13.55 ms, P = 0.799; STEMI: 40.9 +/- 12.62 ins versus 39.19 +/- 11.18 ms, P = 0.132). In addition, we did not find significant difference in atrial electromechanical delay (EMD) with tissue Doppler imaging (interatrial EMD 24.11 +/- 3.06 ins versus 24.46 +/- 3.23 ms, P = 0.279). Conclusion: In conclusion, we did not find any difference in detailed electrocardiographic and echocardiographic parameters as AF predictors between ticagrelor and clopidogrel groups in patients with ACS.

1 February 2023 in Biomarkers in Medicine
Verified
Journal Article
Closed access
FAFaruk Aydınyılmaz
Faruk Aydınyılmaz
IGİlKin Guliyev
İlKin Guliyev
NÖNail Burak Özbeyaz
Nail Burak Özbeyaz
EAEngin Algül
Engin Algül
MAMert Aker
Mert Aker
KKKamuran Kalkan
Kamuran Kalkan
Aim: To appraise the prediction of tricuspid annular plane systolic excursion (TAPSE)/systolic pulmonary artery pressure (SPAP) with regard to hospitalization and the effect of spironolactone use. ...

12 March 2026 in Angiology
Verified
Journal Article
Closed access
MEMuhammed Erzurum
Muhammed Erzurum
MFMehmet Ali Felekoğlu
Mehmet Ali Felekoğlu
NANadire Işık EROL ALGÜL
Nadire Işık EROL ALGÜL
ATAlperen Taş
Alperen Taş
NÖNail Burak Özbeyaz
Nail Burak Özbeyaz
TETolga Han Efe
Tolga Han Efe
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been associated with lower atrial fibrillation (AF) incidence in diabetes mellitus (DM). Atrial electromechanical delay (AEMD) is an electrophysiological marker related to AF development. This study evaluated AEMD changes in type 2 DM patients treated with an SGLT2 inhibitor (dapagliflozin or empagliflozin). Baseline and 4-month follow-up data of 50 patients with type 2 diabetes who initiated SGLT2 inhibitor therapy were retrospectively obtained from medical records and analyzed. AEMD was measured using echocardiography and tissue Doppler. Inter-AEMD and intra-AEMD intervals were calculated. Left atrial volume (LAVOL) significantly decreased (45.23 ± 9.27 vs 42.21 ± 9.16; P < .001), while left intra-AEMD (19.58 ± 7.53 vs 16.76 ± 7.53; P <.001), right intra-AEMD (14.42 ± 5.81 vs 12.46 ± 8.05; P = .016), and inter-AEMD (34 ± 9.41 vs 29.22 ± 9.44; P < .001) were significantly reduced. Inter-AEMD change correlated with LAVOL, E/E′ ratio, body mass index, and mean blood pressure changes (all P <.05). In diabetic patients treated with SGLT2 inhibitors, AEMD reduction was observed after 4 months, with favorable metabolic and hemodynamic effects. These findings suggest that SGLT2 inhibitors may protect against AF by improving atrial electromechanical function.

23 November 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FEFerhat Eyyupkoca
Ferhat Eyyupkoca
NENilnur Eyerci
Nilnur Eyerci
MAMehmet Sait Altintas
Mehmet Sait Altintas
MFMehmet Ali Felekoglu
Mehmet Ali Felekoglu
HBHalil ibrahim Biter
Halil ibrahim Biter
ÖAÖmer Faruk Ateş
Ömer Faruk Ateş
Resumo Fundamento: As matrizes metaloproteinases (MMPs) podem afetar o volume extracelular (VEC) e seus compartimentos, e isso pode oferecer informações mais detalhadas sobre o mecanismo de remodelação adversa (RA) do ventrículo esquerdo (VE) após o infarto agudo do miocárdio (IM). Objetivos: Investigar o papel que as alterações (Δ) nos compartimentos de VEC (volume matriz (MVi) e volume celular (CVi)) desempenham no desenvolvimento de RA após o IM, e sua relação com as expressões de MMP-2. Métodos: Um total de noventa [...] Resumo Fundamento: As matrizes metaloproteinases (MMPs) podem afetar o volume extracelular (VEC) e seus compartimentos, e isso pode oferecer informações mais detalhadas sobre o mecanismo de remodelação adversa (RA) do ventrículo esquerdo (VE) após o infarto agudo do miocárdio (IM). Objetivos: Investigar o papel que as alterações (Δ) nos compartimentos de VEC (volume matriz (MVi) e volume celular (CVi)) desempenham no desenvolvimento de RA após o IM, e sua relação com as expressões de MMP-2. Métodos: Um total de noventa

7 October 2026 in Angiology
Verified
Journal Article
Closed access
NANadire Işık EROL ALGÜL
Nadire Işık EROL ALGÜL
MEMuhammed Erzurum
Muhammed Erzurum
MFMehmet ali Felekoğlu
Mehmet ali Felekoğlu
MÖMehmet Emre Özerdem
Mehmet Emre Özerdem
NÖNail Burak Özbeyaz
Nail Burak Özbeyaz
EAEngin Algül
Engin Algül
Contrast-associated acute kidney injury (CA-AKI) is a serious complication associated with increased morbidity and mortality in patients with acute coronary syndrome (ACS) undergoing coronary angiography. The C-reactive protein-albumin-lymphocyte (CALLY) index is a novel biomarker reflecting inflammatory and nutritional status. This retrospective study evaluated the prognostic value of the CALLY index calculated at hospital admission for predicting CA-AKI in 1516 patients with ACS. CA-AKI developed in 267 patients (17.6%). Patients who developed CA-AKI had significantly lower CALLY index values (0.35 ± 0.16 vs 0.84 ± 0.30; P < .001). In separate multivariable logistic regression analyses adjusted for baseline clinical and procedural confounders, the CALLY index emerged as an independent predictor of CA-AKI (Odds ratio [OR] 0.592 per 0.1-unit increase; 95% CI 0.525-0.668; P < .001). Receiver operating characteristic curve analysis demonstrated good discriminatory capacity for the CALLY index (Area Under the Curve [AUC] = 0.822), significantly outperforming conventional clinical scores and other inflammatory indices (DeLong test P < .001). Furthermore, adding the CALLY index to the Mehran risk score significantly improved reclassification metrics (Net Reclassification Improvement [NRI] = 14.2%, Integrated Discrimination Improvement [IDI] = 0.048; P < .001). The CALLY index serves as a simple, practical, and effective score for early CA-AKI risk stratification in ACS.

1 January 2026 in The Anatolian Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
MEMuhammed Erzurum
Muhammed Erzurum
VTVEYSEL OZAN TANIK
VEYSEL OZAN TANIK
ATAlperen Taş
Alperen Taş
MÖMehmet Taha Özkan
Mehmet Taha Özkan
TKTuğba Kapanşahin
Tuğba Kapanşahin
KKKamuran Kalkan
Kamuran Kalkan
Background: Early risk stratification is essential in patients with non–ST-segment elevation myocardial infarction (NSTEMI). The Endothelial Activation and Stress Index (EASIX) reflects endothelial dysfunction and systemic stress; however, its prognostic value in NSTEMI remains unclear. This study aimed to investigate the association between EASIX and in-hospital mortality in patients with NSTEMI. Methods: This retrospective, single-center observational study included 1001 consecutive NSTEMI patients hospitalized between January 2015 and August 2025. Endothelial Activation and Stress Index was calculated at admission using lactate dehydrogenase, creatinine, and platelet count. Univariable and multivariable logistic regression analyses were performed to identify independent predictors of in-hospital mortality. Discriminative performance was assessed using receiver operating characteristic analysis and Kaplan–Meier survival analysis. Results: In-hospital mortality occurred in 41 patients (4.1%). Non-survivors had significantly higher EASIX values than survivors (median 1.76 vs. 0.94, P < .001). In multivariable analysis, EASIX (OR 1.66, 95% CI 1.24-2.23; P = .001), GRACE score (OR 1.04, 95% CI 1.03-1.06; P < .001), and revascularization (OR 0.37, 95% CI 0.15-0.55; P = .003) remained independent predictors of in-hospital mortality. EASIX demonstrated good discriminative ability (AUC 0.770), and higher levels were associated with worse survival. Conclusion: Endothelial Activation and Stress Index is an independent and practical predictor of in-hospital mortality in NSTEMI and may aid early risk stratification using routine laboratory data.